Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a glass of water replace IV fluids in the ICU? small study investigates

NCT ID NCT03951519

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether giving water through a feeding tube works as well as IV saline for fluid expansion in 50 ICU patients on ventilators with low blood pressure. Researchers measured changes in heart function and blood flow. The goal was to gather initial data to design larger studies, not to prove which method is better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
oral water
What this could lead to
If successful, this could show that giving water through a feeding tube is a safe and effective way to help stabilize blood pressure in ICU patients, potentially reducing side effects from IV fluids.
What could go wrong
This is a very small pilot study with only 50 patients, so results may not apply to all ICU patients. The study is designed to gather information, not to prove that water is better than saline.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

May 2019

Finished

Jan 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Close family member has given written consent for patient included in emergency * Intubated-ventilated patient in controlled volume mode * Normothermal patient (36.5-37.5°C) * Adult patient in intensive care for whom the attending physician has decided to give fluid expansion because of acute circulatory failure (systolic blood pressure \< 90 mmHg, and/or mean blood pressure \< 65 mmHg, and/or the need for infusion of vasopressor amines, and/or skin mottles, and/or diuresis \< 0.5 mL/kg/h for a duration of ≥ 2 hours, and/or arterial lactate level \> 2 mmol/L) (21), * Patient with a variation OF SV over 10% with PLR, * Echogenic patient, * Patient with a regular sinus rhythm, * Patient with a nasogastric tube. Exclusion Criteria: * Person subject to a legal protection measure (curatorship, guardianship) * Person subject to a measure to safeguard justice * Condition contraindicating the use of the oral route, * Patient not affiliated or not covered by the national health system, * Pregnant, parturient or breastfeeding woman, * Hemodynamically unstable patient (variation of more than 10% in blood pressure), * Arrhythmia-like rhythm disorder by atrial fibrillation, * Modification of therapies (sedation, catecholamines) during the study period, * Modification of the ventilatory parameters. * Heart failure * Oedemato-ascitic insufficiency of cirrhosis * Changes in drug doses

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intubated-ventilated patients in the intensive care unit are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chu Dijon Bourogne

    Dijon, 21000, France